MULHEIM, GERMANY: Brenntag AG said it has entered the micronization and fine milling segment by acquiring ACU pharma und Chemie group (ACU) in Germany.
ACU specializes in the milling and micronization of products and compound mixtures. In its modern facility, the company produces high quality powders for customers in many different industries. Besides this custom-made contract manufacturing, ACU sells its own micronized products, especially lithium carbonate.
The acquired business generated sales of approximately €4.5 million in 2015.
“This acquisition is attractive for several reasons. Brenntag can profit from the outsourcing trend among chemical producers in areas such as micronization which are not core business activities. In addition, we are breaking into the attractive lithium-carbonate distribution business in Germany, Austria and Switzerland,” said Anthony Gerace, managing director, mergers & acquisitions, Brenntag Group.
“The core competence of ACU in the area of ultra-fine milling of solids allows us to continue expanding our portfolio of value-added services, particularly for customers in the Life Science segment. The acquisition brings us powerful expertise as well as plant technology for a variety of services,” said Karsten Beckmann, management board member, Brenntag Group and CEO Brenntag, Europe, Middle East and Africa.
© Worldofchemicals News